SALADINI FRANCESCO

Francesco
Saladini
Ricercatore Legge 240/10 - tempo determinato

Attività didattica

ANNO ACCADEMICO DI ESPLETAMENTO: 2019/2020

Attività di ricerca

Ultime pubblicazioni:

  • BRAI, A., Riva, V., SALADINI, F., ZAMPERINI, C., TRIVISANI, C.I., Garbelli, A., et al. (In corso di stampa). DDX3X inhibitors, an effective way to overcome HIV-1 resistance. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - dettaglio
  • Saladini, F., Giannini, A., Boccuto, A., Dragoni, F., Appendino, A., Albanesi, E., et al. (2020). Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64(1). - dettaglio
  • Dragoni, F., Boccuto, A., Picarazzi, F., Giannini, A., Giammarino, F., Saladini, F., et al. (2020). Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. ANTIVIRAL RESEARCH. - dettaglio
  • Humbert, N., Kovalenko, L., Saladini, F., Giannini, A., Pires, M., Botzanowski, T., et al. (2020). (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity. ACS INFECTIOUS DISEASES. - dettaglio
  • Vicenti, I., Dragoni, F., Giannini, A., Giammarino, F., Spinicci, M., Saladini, F., et al. (2020). Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. SLAS DISCOVERY. - dettaglio